MEDSCIENCE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDSCIENCE
Largest movements
- Current investments -€65,000
down €65,000 (-11.8%), from €550,000 to €485,000
- Cash +€43,941
up €43,941 (+11.7%), from €376,260 to €420,201
mainly Other debts (+€254,351) and Net result for the year (+€68,808)
- Tangible fixed assets +€30,356
up €30,356 (+47.5%), from €63,901 to €94,257
of which Furniture and vehicles: +€31,279
- Receivables within one year +€22,019
up €22,019 (+530.3%), from €4,152 to €26,171
- Other debts +€254,351
new in 2025: €254,351
- Reserves -€201,171
down €201,171 (-21.0%), from €957,064 to €755,893
of which Distributable reserves: -€201,171
- Tax, wage and social debts -€14,115
down €14,115 (-84.6%), from €16,687 to €2,573
- Gross operating margin -€107,994
down €107,994 (-58.4%), from €185,037 to €77,042
- Financial income +€35,774
up €35,774 (+991.1%), from €3,610 to €39,383
of which Financial income: +€26,763
- Taxes -€25,739
down €25,739 (-44.1%), from €58,334 to €32,595
- Depreciation +€2,294
up €2,294 (+22.1%), from €10,399 to €12,693
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €995,544 | €1,035,962 | +€40,418 | +4.1% |
| Fixed assets | 21/28 | €63,901 | €94,257 | +€30,356 | +47.5% |
| Tangible fixed assets | 22/27 | €63,901 | €94,257 | +€30,356 | +47.5% |
| Plant, machinery and equipment | 23 | €3,857 | €2,934 | -€923 | -23.9% |
| Furniture and vehicles | 24 | €60,044 | €91,323 | +€31,279 | +52.1% |
| Financial fixed assets | 28 | €0 | - | = | |
| Current assets | 29/58 | €931,644 | €941,706 | +€10,062 | +1.1% |
| Amounts receivable within one year | 40/41 | €4,152 | €26,171 | +€22,019 | +530.3% |
| Other amounts receivable | 41 | €4,152 | €26,171 | +€22,019 | +530.3% |
| Current investments | 50/53 | €550,000 | €485,000 | -€65,000 | -11.8% |
| Cash at bank and in hand | 54/58 | €376,260 | €420,201 | +€43,941 | +11.7% |
| Deferred charges and accrued income | 490/1 | €1,232 | €10,333 | +€9,101 | +738.9% |
| Total equity and liabilities | 10/49 | €995,544 | €1,035,962 | +€40,418 | +4.1% |
| Equity | 10/15 | €977,406 | €774,485 | -€202,921 | -20.8% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €957,064 | €755,893 | -€201,171 | -21.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €957,064 | €755,893 | -€201,171 | -21.0% |
| Profit (loss) carried forward | 14 | €1,750 | €0 | -€1,750 | -100.0% |
| Amounts payable | 17/49 | €18,138 | €261,477 | +€243,338 | +1341.6% |
| Amounts payable within one year | 42/48 | €18,138 | €259,777 | +€241,638 | +1332.2% |
| Trade debts | 44 | €1,451 | €2,853 | +€1,402 | +96.6% |
| Suppliers | 440/4 | €1,451 | €2,853 | +€1,402 | +96.6% |
| Taxes, remuneration and social security | 45 | €16,687 | €2,573 | -€14,115 | -84.6% |
| Taxes | 450/3 | €16,687 | €2,573 | -€14,115 | -84.6% |
| Other amounts payable | 47/48 | - | €254,351 | +€254,351 | |
| Accrued charges and deferred income | 492/3 | - | €1,700 | +€1,700 | |
| Remuneration, social security and pensions | 62 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,399 | €12,693 | +€2,294 | +22.1% |
| Other operating charges | 640/8 | €500 | €740 | +€240 | +47.9% |
| Gross operating margin | 9900 | €185,037 | €77,042 | -€107,994 | -58.4% |
| Operating profit (loss) | 9901 | €174,137 | €63,609 | -€110,528 | -63.5% |
| Financial income | 75/76B | €3,610 | €39,383 | +€35,774 | +991.1% |
| Recurring financial income | 75 | €3,610 | €30,373 | +€26,763 | +741.5% |
| Non-recurring financial income | 76B | - | €9,011 | +€9,011 | |
| Financial charges | 65/66B | €310 | €1,590 | +€1,280 | +412.9% |
| Recurring financial charges | 65 | €310 | €1,590 | +€1,280 | +412.9% |
| Profit (loss) for the period before taxes | 9903 | €177,437 | €101,402 | -€76,034 | -42.9% |
| Income taxes | 67/77 | €58,334 | €32,595 | -€25,739 | -44.1% |
| Profit (loss) for the period | 9904 | €119,103 | €68,808 | -€50,295 | -42.2% |
| Profit (loss) for the period to be appropriated | 9905 | €119,103 | €68,808 | -€50,295 | -42.2% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.